Cargando…
The autotaxin-lysophosphatidic acid–lysophosphatidic acid receptor cascade: proposal of a novel potential therapeutic target for treating glioblastoma multiforme
Glioblastoma multiforme (GBM) is the most malignant tumor of the central nervous system (CNS). Its prognosis is one of the worst among all cancer types, and it is considered a fatal malignancy, incurable with conventional therapeutic strategies. As the bioactive multifunctional lipid mediator lysoph...
Autor principal: | Tabuchi, Sadaharu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4477515/ https://www.ncbi.nlm.nih.gov/pubmed/26084470 http://dx.doi.org/10.1186/s12944-015-0059-5 |
Ejemplares similares
-
2-Carba-lysophosphatidic acid is a novel β-lysophosphatidic acid analogue with high potential for lysophosphatidic acid receptor activation and autotaxin inhibition
por: Fukasawa, Keiko, et al.
Publicado: (2021) -
Autotaxin–Lysophosphatidic Acid Signaling in Alzheimer’s Disease
por: Ramesh, Sindhu, et al.
Publicado: (2018) -
Autotaxin-Lysophosphatidic Acid: From Inflammation to Cancer Development
por: Valdés-Rives, Silvia Anahi, et al.
Publicado: (2017) -
Linking medicinal cannabis to autotaxin–lysophosphatidic acid signaling
por: Eymery, Mathias C, et al.
Publicado: (2023) -
Roles of Autotaxin/Autotaxin-Lysophosphatidic Acid Axis in the Initiation and Progression of Liver Cancer
por: She, Sha, et al.
Publicado: (2022)